Skip to main content
NCBI home page
Journal of Clinical Pathology. Supplement (Association of Clinical Pathologists) logoLink to Journal of Clinical Pathology. Supplement (Association of Clinical Pathologists)
. 1978;8:58–62. doi: 10.1136/jcp.s1-8.1.58

Gut glucagon-like immunoreactants (GLIs) and other enteric glucagon-like peptides.

A J Moody
PMCID: PMC1436052  PMID: 298739

Full text

PDF
58

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Assan R., Slusher N. Structure-function and structure-immunoreactivity relationships of the glucagon molecule and related synthetic peptides. Diabetes. 1972 Aug;21(8):843–855. doi: 10.2337/diab.21.8.843. [DOI] [PubMed] [Google Scholar]
  2. Bataille D., Freychet P., Rosselin G. Interactions of glucagon, gut glucagon, vasoactive intestinal polypeptide and secretin with liver and fat cell plasma membranes: binding to specific sites and stimulation of adenylate cyclase. Endocrinology. 1974 Sep;95(3):713–721. doi: 10.1210/endo-95-3-713. [DOI] [PubMed] [Google Scholar]
  3. Bussolati G., Capella C., Vassallo G., Solcia E. Histochemical and ultrastructural studies on pancreatic A cells. Evidence for glucagon and non-glucagon components of the alpha granule. Diabetologia. 1971 Jun;7(3):181–188. doi: 10.1007/BF01212551. [DOI] [PubMed] [Google Scholar]
  4. Garaud J. C., Moody A. J., Eloy R., Grenier J. F. Unusual specificities of antibodies to glucagon-glutaraldehyde-albumin conjugates. Horm Metab Res. 1976 May;8(3):241–243. doi: 10.1055/s-0028-1095608. [DOI] [PubMed] [Google Scholar]
  5. Heding L. G., Frandsen E. K., Jacobsen H. Structure-function relationship: immunologic. Metabolism. 1976 Nov;25(11 Suppl 1):1327–1329. doi: 10.1016/s0026-0495(76)80134-5. [DOI] [PubMed] [Google Scholar]
  6. Jacobsen H., Demandt A., Moody A. J., Sundby F. Sequence analysis of porcine gut GLI-1. Biochim Biophys Acta. 1977 Aug 23;493(2):452–459. doi: 10.1016/0005-2795(77)90201-x. [DOI] [PubMed] [Google Scholar]
  7. Krug E., Mialhe P. A possible role for gut GLI: an inhibitor of lipolysis. Horm Metab Res. 1977 Nov;9(6):465–469. doi: 10.1055/s-0028-1093501. [DOI] [PubMed] [Google Scholar]
  8. Orci L., Pictet R., Forssmann W. G., Renold A. E., Rouiller C. Structural evidence for glucagon producing cells in the intestinal mucosa of the rat. Diabetologia. 1968 Jan;4(1):56–67. doi: 10.1007/BF01241034. [DOI] [PubMed] [Google Scholar]
  9. Ravazzola M., Siperstein A., Moody A. J., Sundby F., Jacobsen H., Orci L. Glicentin immunoreactive cells: their relationship to glucagon-producing cells. Endocrinology. 1979 Aug;105(2):499–508. doi: 10.1210/endo-105-2-499. [DOI] [PubMed] [Google Scholar]
  10. STAUB A., SINN L., BEHRENS O. K. Purification and crystallization of hyperglycemic glycogenolytic factor (HGF). Science. 1953 Jun 5;117(3049):628–629. doi: 10.1126/science.117.3049.628. [DOI] [PubMed] [Google Scholar]
  11. Sundby F., Jacobsen H., Moody A. J. Purification and characterization of a protein from porcine gut with glucagon-like immunoreactivity. Horm Metab Res. 1976 Sep;8(5):366–371. doi: 10.1055/s-0028-1093615. [DOI] [PubMed] [Google Scholar]
  12. Sundby F. Species variations in the primary structure of glucagon. Metabolism. 1976 Nov;25(11 Suppl 1):1319–1321. doi: 10.1016/s0026-0495(76)80132-1. [DOI] [PubMed] [Google Scholar]
  13. Tager H. S., Steiner D. F. Isolation of a glucagon-containing peptide: primary structure of a possible fragment of proglucagon. Proc Natl Acad Sci U S A. 1973 Aug;70(8):2321–2325. doi: 10.1073/pnas.70.8.2321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Tanaka R., Matsuyama T., Shima K., Sawazaki N., Tarui S., Kumahara Y. Insulin releasing activity of gastrointestinal glucagon-like immunoreactive materials in perfused rat pancreas. Endocrinol Jpn. 1977 Dec;24(6):575–579. doi: 10.1507/endocrj1954.24.575. [DOI] [PubMed] [Google Scholar]
  15. Unger R. H., Ohneda A., Valverde I., Eisentraut A. M., Exton J. Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose. J Clin Invest. 1968 Jan;47(1):48–65. doi: 10.1172/JCI105714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Valverde I., Rigopoulou D., Marco J., Faloona G. R., Unger R. H. Characterization of glucagon-like immunoreactivity (GLI). Diabetes. 1970 Sep;19(9):614–623. doi: 10.2337/diab.19.9.614. [DOI] [PubMed] [Google Scholar]
  17. Vranic M., Engerman R., Doi K., Morita S., Yip C. C. Extrapancreatic glucagon in the dog. Metabolism. 1976 Nov;25(11 Suppl 1):1469–1473. doi: 10.1016/s0026-0495(76)80169-2. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology. Supplement (Ass. Clin. Path.) are provided here courtesy of BMJ Publishing Group

RESOURCES